A citation-based method for searching scientific literature

Donald A Berry, Kathleen A Cronin, Sylvia K Plevritis, Dennis G Fryback, Lauren Clarke, Marvin Zelen, Jeanne S Mandelblatt, Andrei Y Yakovlev, J Dik F Habbema, Eric J Feuer. N Engl J Med 2005
Times Cited: 1613







List of co-cited articles
282 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
20

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
Sylvia K Plevritis, Diego Munoz, Allison W Kurian, Natasha K Stout, Oguzhan Alagoz, Aimee M Near, Sandra J Lee, Jeroen J van den Broek, Xuelin Huang, Clyde B Schechter,[...]. JAMA 2018
110
14

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
828
10

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
9

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
9

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
9

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
6


Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I Neugut. J Clin Oncol 2010
515
4

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
740
4

Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, Ann Goding Sauer, Lisa A Newman, Ahmedin Jemal. CA Cancer J Clin 2017
815
4

Breast-cancer screening--viewpoint of the IARC Working Group.
Béatrice Lauby-Secretan, Chiara Scoccianti, Dana Loomis, Lamia Benbrahim-Tallaa, Véronique Bouvard, Franca Bianchini, Kurt Straif. N Engl J Med 2015
348
4


Cancer treatment and survivorship statistics, 2019.
Kimberly D Miller, Leticia Nogueira, Angela B Mariotto, Julia H Rowland, K Robin Yabroff, Catherine M Alfano, Ahmedin Jemal, Joan L Kramer, Rebecca L Siegel. CA Cancer J Clin 2019
4

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
4

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Javaid Iqbal, Ophira Ginsburg, Paula A Rochon, Ping Sun, Steven A Narod. JAMA 2015
324
4

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.
Diego Munoz, Aimee M Near, Nicolien T van Ravesteyn, Sandra J Lee, Clyde B Schechter, Oguzhan Alagoz, Donald A Berry, Elizabeth S Burnside, Yaojen Chang, Gary Chisholm,[...]. J Natl Cancer Inst 2014
78
5

Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.
Nicolien T van Ravesteyn, Jeroen J van den Broek, Xiaoxue Li, Harald Weedon-Fekjær, Clyde B Schechter, Oguzhan Alagoz, Xuelin Huang, Donald L Weaver, Elizabeth S Burnside, Rinaa S Punglia,[...]. Med Decis Making 2018
14
21

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
181
3

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
487
3


Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
Caitlin C Murphy, L Kay Bartholomew, Melissa Y Carpentier, Shirley M Bluethmann, Sally W Vernon. Breast Cancer Res Treat 2012
355
3

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
Therese B Bevers, Mark Helvie, Ermelinda Bonaccio, Kristine E Calhoun, Mary B Daly, William B Farrar, Judy E Garber, Richard Gray, Caprice C Greenberg, Rachel Greenup,[...]. J Natl Compr Canc Netw 2018
123
3

Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
279
3

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, I T Rubio, S Zackrisson, E Senkus. Ann Oncol 2019
365
3

Mammographic density and the risk and detection of breast cancer.
Norman F Boyd, Helen Guo, Lisa J Martin, Limei Sun, Jennifer Stone, Eve Fishell, Roberta A Jong, Greg Hislop, Anna Chiarelli, Salomon Minkin,[...]. N Engl J Med 2007
3


American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
3

Breast cancer screening using tomosynthesis in combination with digital mammography.
Sarah M Friedewald, Elizabeth A Rafferty, Stephen L Rose, Melissa A Durand, Donna M Plecha, Julianne S Greenberg, Mary K Hayes, Debra S Copit, Kara L Carlson, Thomas M Cink,[...]. JAMA 2014
451
3

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
3

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Leah K Lambert, Lynda G Balneaves, A Fuchsia Howard, Carolyn C Gotay. Breast Cancer Res Treat 2018
48
6

Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities.
Richard B Warnecke, April Oh, Nancy Breen, Sarah Gehlert, Electra Paskett, Katherine L Tucker, Nicole Lurie, Timothy Rebbeck, James Goodwin, John Flack,[...]. Am J Public Health 2008
283
3



Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, H C Pan, M Clarke, D Cutter, S Darby, P McGale, C Taylor,[...]. Lancet 2012
3

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Jeanne S Mandelblatt, Natasha K Stout, Clyde B Schechter, Jeroen J van den Broek, Diana L Miglioretti, Martin Krapcho, Amy Trentham-Dietz, Diego Munoz, Sandra J Lee, Donald A Berry,[...]. Ann Intern Med 2016
129
3

Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.
Jeroen J van den Broek, Nicolien T van Ravesteyn, Eveline A Heijnsdijk, Harry J de Koning. Med Decis Making 2018
18
16

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.
Jeanne S Mandelblatt, Aimee M Near, Diana L Miglioretti, Diego Munoz, Brian L Sprague, Amy Trentham-Dietz, Ronald Gangnon, Allison W Kurian, Harald Weedon-Fekjaer, Kathleen A Cronin,[...]. Med Decis Making 2018
27
11

The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Ronald E Gangnon, Brian L Sprague, Natasha K Stout, Oguz Alagoz, Harald Weedon-Fekjær, Theodore R Holford, Amy Trentham-Dietz. Cancer Epidemiol Biomarkers Prev 2015
37
8

Breast cancer early detection: A phased approach to implementation.
Ophira Ginsburg, Cheng-Har Yip, Ari Brooks, Anna Cabanes, Maira Caleffi, Jorge Antonio Dunstan Yataco, Bishal Gyawali, Valerie McCormack, Myrna McLaughlin de Anderson, Ravi Mehrotra,[...]. Cancer 2020
40
7

Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda.
Lydia E Pace, Tharcisse Mpunga, Vedaste Hategekimana, Jean-Marie Vianney Dusengimana, Hamissy Habineza, Jean Bosco Bigirimana, Cadet Mutumbira, Egide Mpanumusingo, Jean Paul Ngiruwera, Neo Tapela,[...]. Oncologist 2015
90
3

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
440
3

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
413
3

Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007.
Benjamin O Anderson, Cheng-Har Yip, Robert A Smith, Roman Shyyan, Stephen F Sener, Alexandru Eniu, Robert W Carlson, Edward Azavedo, Joe Harford. Cancer 2008
285
3

Breast cancer. Clinical practice guidelines in oncology.
Robert W Carlson, D Craig Allred, Benjamin O Anderson, Harold J Burstein, W Bradford Carter, Stephen B Edge, John K Erban, William B Farrar, Lori J Goldstein, William J Gradishar,[...]. J Natl Compr Canc Netw 2009
346
3

Diagnosis and surgical delays in African American and white women with early-stage breast cancer.
Prethibha George, Sheenu Chandwani, Molly Gabel, Christine B Ambrosone, George Rhoads, Elisa V Bandera, Kitaw Demissie. J Womens Health (Larchmt) 2015
42
7

Association of insurance with cancer care utilization and outcomes.
Elizabeth Ward, Michael Halpern, Nicole Schrag, Vilma Cokkinides, Carol DeSantis, Priti Bandi, Rebecca Siegel, Andrew Stewart, Ahmedin Jemal. CA Cancer J Clin 2008
487
3

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
3


Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Rochelle Fu, Amy Cantor, Miranda Pappas, Monica Daeges, Linda Humphrey. Ann Intern Med 2016
221
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.